BackUV Flu Technologies Overview

UV Flu Technologies EBIT

Latest ebit for UVFT: $-670K, below the sector sector average of $2.5T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$89.28K
↑ 25.77% YoY

As of Mar 31, 2016

Annual EBIT (TTM)

-$672.35K
↑ 29.62% YoY

Trailing 12 months ending Mar 31, 2016

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

UV Flu Technologies (UVFT) FAQ

UV Flu Technologies (UVFT) currently reports a EBIT of $-670K as of March 2016. That compares with $-960K in the prior-year period — up 29.6% year over year. That is below the sector sector average of $2.5T. Use the charts on this page to explore UV Flu Technologies's EBIT history and peer comparisons.

UV Flu Technologies's EBIT increased from $-960K to $-670K — a 29.6% year-over-year increase (period ending March 2016). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

UV Flu Technologies's EBIT of $-670K is lower than the its sector sector average of $2.5T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

UV Flu Technologies reported $-670K in EBIT as of March 2016. That compares with $-960K in the prior-year period — up 29.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-670K, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.5T. From there, open related valuation or income-statement pages for UV Flu Technologies, and consider following UVFT for alerts when major investors trade the stock.